What’s Going on at KUIC

KU start-up school gains popularity among students

If the University of Kansas (KU) experience with its free mini-course Startup School@KU is any indication, universities that want to tap into student demand for more entrepreneurship opportunities should take note.

October 19, 2016, Read more

KU promotes innovation with new Proof of Concept Fund Awards

Demonstrating that a laboratory concept will work in practice is one key to moving a research discovery into the marketplace. The University of Kansas supports discovery and innovation in multiple ways, including the granting of Proof of Concept (POC) Fund awards for inventions that are near the commercialization stage.

Julie Nagel Named Associate Vice Chancellor for Innovation and Entrepreneurship at KU

Julie Nagel, the interim associate vice chancellor for innovation and entrepreneurship at the University of Kansas, has been named to the position permanently. In that role she serves as president of KU Innovation and Collaboration (KUIC), which manages intellectual property and technology commercialization at all KU campuses. She also provides leadership for the university’s overall economic development mission. The appointment is effective immediately.

Kansas City just launched a $10M co-investment fund for its startup community

Called KCRise, it's from a consortium of local economic development groups aiming to grow the amount of venture capital flowing into the City of Fountains.

KU Startup School Equips Faculty and Students for Entrepreneurships

t the University of Kansas, an innovative program gives faculty, staff and students the tools and knowledge they need to succeed as entrepreneurs. Best of all, they learn the ropes from people with experience, enthusiasm and a spirit of adventure.

A new study finds the drug Arimoclomol shows promise in treating inclusion body myositis

A new drug to treat the muscle-wasting disease inclusion body myositis (IBM) reverses key symptoms in mice and is safe and well-tolerated in patients, finds a new study led by the Medical Research Council (MRC) Centre for Neuromuscular Diseases at UCL and the University of Kansas Medical Center.